TR199800801T2 - Treatment of traumatic brain injuries. - Google Patents

Treatment of traumatic brain injuries.

Info

Publication number
TR199800801T2
TR199800801T2 TR1998/00801T TR9800801T TR199800801T2 TR 199800801 T2 TR199800801 T2 TR 199800801T2 TR 1998/00801 T TR1998/00801 T TR 1998/00801T TR 9800801 T TR9800801 T TR 9800801T TR 199800801 T2 TR199800801 T2 TR 199800801T2
Authority
TR
Turkey
Prior art keywords
traumatic brain
treatment
brain injuries
injuries
injury
Prior art date
Application number
TR1998/00801T
Other languages
Turkish (tr)
Inventor
R. Pike Brian
Original Assignee
H. Lund-Beck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lund-Beck A/S filed Critical H. Lund-Beck A/S
Publication of TR199800801T2 publication Critical patent/TR199800801T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Formül I'in bilesigi 5-(2-etil-2H-tetrazol-5-il) -1,2,3,6-tetrahidro-1-metilpiridin travmatik beyin yaralanmasi örneklerinde anlama performansini artirir ve kolinerjik nöronlarin yaralanma hasarlarini azaltir ve travmatik beyin yaralanmalarinin tedavisinde kullanilan farmasötik ilaçlarin imal edilmesi için faydalidir.The compound of formula I 5- (2-ethyl-2H-tetrazol-5-yl) -1,2,3,6-tetrahydro-1-methylpyridine improves understanding performance in traumatic brain injury samples and reduces injury injuries of cholinergic neurons and traumatic brain It is useful for the manufacture of pharmaceutical drugs used in the treatment of injuries.

TR1998/00801T 1995-11-06 1996-11-05 Treatment of traumatic brain injuries. TR199800801T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06

Publications (1)

Publication Number Publication Date
TR199800801T2 true TR199800801T2 (en) 1998-08-21

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00801T TR199800801T2 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injuries.

Country Status (18)

Country Link
EP (1) EP0866706A1 (en)
JP (1) JPH11514654A (en)
KR (1) KR19990067353A (en)
AU (1) AU706594B2 (en)
BG (1) BG63150B1 (en)
BR (1) BR9611396A (en)
CA (1) CA2234824A1 (en)
CZ (1) CZ287441B6 (en)
EA (1) EA000531B1 (en)
HU (1) HUP9901051A2 (en)
IS (1) IS4726A (en)
NO (1) NO982036L (en)
NZ (1) NZ321546A (en)
PL (1) PL326490A1 (en)
SK (1) SK58198A3 (en)
TR (1) TR199800801T2 (en)
WO (1) WO1997017074A1 (en)
ZA (1) ZA969320B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (en) * 1997-07-01 2000-12-13 Lundbeck & Co As H SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
BG102480A (en) 1999-01-29
ZA969320B (en) 1997-05-30
CZ138998A3 (en) 1998-10-14
NO982036L (en) 1998-06-25
BG63150B1 (en) 2001-05-31
SK58198A3 (en) 1998-10-07
EP0866706A1 (en) 1998-09-30
NO982036D0 (en) 1998-05-05
NZ321546A (en) 2000-12-22
KR19990067353A (en) 1999-08-16
EA000531B1 (en) 1999-10-28
EA199800434A1 (en) 1998-10-29
CA2234824A1 (en) 1997-05-15
AU7490096A (en) 1997-05-29
MX9803432A (en) 1998-09-30
IS4726A (en) 1998-04-27
AU706594B2 (en) 1999-06-17
CZ287441B6 (en) 2000-11-15
BR9611396A (en) 1999-07-13
JPH11514654A (en) 1999-12-14
PL326490A1 (en) 1998-09-28
WO1997017074A1 (en) 1997-05-15
HUP9901051A2 (en) 2000-03-28

Similar Documents

Publication Publication Date Title
NL300140I2 (en) Galanthamine, or compounds analogous thereto, for treatment of Alzheimer's disease.
NO871549D0 (en) MEDICINES FOR TREATMENT OF EYE INJURIES.
ATE224714T1 (en) TREATING TINNITUS WITH NEUROPROTECTIVE ACTIVES
FI964771A0 (en) (a) annealed pyrrole derivatives and their use in pharmacin
ES2191075T3 (en) 8-ARILALQUIL- AND 8-ARILHETEROALQUIL-5,11-DIHIDRO-6H-DIPIRIDO- (3,2-B: 2 ', 3'-E) (1,4) DIAZEPINS AND THEIR USE IN THE PREVENTION OR TREATMENT OF INFECTIONS FOR HIV.
DK465488D0 (en) PHARMACEUTICAL PREPARATION CONTAINING A TRIAZOL COMPOUND
FR2711140B1 (en) 1-Naphtylpyrazole-3-substituted carboxamides active on neurotensin, their preparation, pharmaceutical compositions containing them.
DE68913739T2 (en) COSMETIC AND SKIN TREATMENT COMPOSITIONS.
DK0604183T3 (en) HIV protease inhibitors useful in the treatment of AIDS
TR199800801T2 (en) Treatment of traumatic brain injuries.
DK0562705T3 (en) Use of L-deprenyl in the manufacture of a drug for the treatment of Cushing's disease
ATE141605T1 (en) THIENOTRIAZOLDIAZEPINE COMPOUNDS AND THEIR PHARMACEUTICAL USES
DK0578477T3 (en) Treatment of inflammatory bowel disease
DE69210091T2 (en) Leukotriene B4 antagonists
ATE141796T1 (en) 2',5'-OLIGOADENYLATE DERIVATIVES FOR USE AS REMEDIES
DE69419954T2 (en) Medicines for the treatment of skin diseases
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
IT1288399B1 (en) MEDICATION FOR THE THERAPEUTIC TREATMENT OF AGE-RELATED MACULOPATHY, NON-AGE-RELATED MACULOPATHY AND FOR PROPHYLAXIS
DE69334087D1 (en) Drug composition containing TCF-II
TR199802200A2 (en) S �lfonamid s �bstit �e edilmi � benzopiran t �revleri, �retilme y �ntemi.
ATE75399T1 (en) THERAPEUTIC FOR TREATMENT OF STOMACH ULCERS.
DE3872425D1 (en) SUBSTITUTED TETRAHYDROISOCHINOLINE COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL AGENTS CONTAINING THEM.
DE69327074T2 (en) Substituted 1,2,4-triazine-3,5-dione derivatives and medicaments containing them, in particular for the treatment of coccidiosis
DE69737088D1 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF FIV INFECTIONS
PT889044E (en) DERIVATIVES OF 5- (HETEROARIL) ALTAL-3-OXO-PYRID- (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE (GDP) USEFUL IN TREATING PERTURBACTIONS OF THE CENTRAL NERVOUS SYSTEM